GlassScriptPhysician profile
Hongling Du
NPI 1508266438
$770.11
in general payments reported to CMS, 2019-2025
11 companies · $53.21 in 2025
The $53.21 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.82 · 2021: $617 · 2022: $16.74 · 2023: $11.36 · 2024: $36.53 · 2025: $53.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $463.35 | 2021 | |
| Karl Storz Endoscopy-America | $108.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.74 | 2020-2025 | |
| Myovant Sciences INC. | $27.70 | 2021 | |
| Sumitomo Pharma America, INC. | $23.37 | 2025 | Myfembree |
| Exeltis, USA INC. | $20.98 | 2024 | Slynd |
| Agile Therapeutics, INC. | $18.38 | 2021 | |
| Therapeuticsmd, INC. | $16.74 | 2022 | |
| Astellas Pharma US INC | $13.79 | 2025 | Veozah |
| Allergan, INC. | $12.68 | 2020 | |
| Intuitive Surgical, INC. | $11.36 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hongling Du listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.